“We really want to be a strong partner for our blood center customers in helping them deliver their important mission, which is to provide safe blood for patients.”

William ‘Obi’ M. Greenman President and CEO, Cerus.

 

View the video

Pathogen Reduced Cryoprecipitated Fibrinogen Complex

Visit product website

INTERCEPT® Blood System for Platelets and Plasma

Visit US SiteVisit International Site

At Cerus, we are proud of our consistent and unwavering focus to secure blood safety around the globe.

See Mission and Values

Annual Report

Annual Report 2021

Cerus’ Annual Meeting of Stockholders was held online on Tuesday, June 3, 2025.
Click the link below to access the Annual Meeting webcast.

Latest Press Releases

10/16/2025
Cerus Corporation to Release Third Quarter 2025 Financial Results on November 6, 2025

08/25/2025
The German National Blood Advisory Committee Issues Formal Recommendation for Improving the Safety of Platelet Transfusions

08/21/2025
Cerus Corporation to Participate in the Cantor Global Healthcare Conference 2025

08/05/2025
Cerus Corporation Announces Second Quarter 2025 Financial Results